Literature DB >> 7834836

Inositol phosphate release and metabolism in rat left atria.

E A Woodcock1, M B Suss, K E Anderson.   

Abstract

The phosphatidylinositol (PtdIns) turnover pathway in intact heart tissue differs from that in most cell types in that products of the inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] kinase pathway are not detected in 3H-labeling studies. In contrast, Ins(1,4,5)P3 kinase products are detected in isolated neonatal cardiomyocytes. To understand the basis for the observed properties of the cardiac pathway, a detailed study of inositol phosphate (InsP) release has been undertaken by using isolated adult rat left atria. Addition of norepinephrine to 3H-labeled atria caused a slow increase in 3H-labeled Ins(1,4,5)P3 and a more rapid increase in 3H-labeled Ins(1,4)P2, its immediate dephosphorylation product. The mass of Ins(1,4,5)P3 was high in unstimulated atria (13.5 +/- 1.1 pmol/mg tissue, mean +/- SEM, n = 4) and did not change with stimulation. Measurements of the specific activities of Ins(1,4,5)P3 and PtdIns(4,5)P2 provided an estimate of the turnover rate of Ins(1,4,5)P3 that was 20- to 40-fold lower than the rate of accumulation of 3H label in InsP1 and InsP2. In agreement with this, specific activities of InsP1 and InsP2 were higher than the specific activity of InsP3 in both control and stimulated atria. Neomycin (5 mmol/L) did not inhibit the accumulation of 3H-labeled InsP1 and InsP2 in left atria, even though it reduced the accumulation of 3H label in Ins(1,4,5)P3, providing evidence that InsP1 and InsP2 do not derive primarily from Ins(1,4,5)P3. Stimulation with norepinephrine for 20 minutes resulted in a parallel decrease in 3H-labeled Ins(1,4,5)P3 and in Ins(1,4,5)P3 mass, demonstrating that atria do not contain two different pools of Ins(1,4,5)P3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7834836     DOI: 10.1161/01.res.76.2.252

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  8 in total

Review 1.  Local calcium gradients during excitation-contraction coupling and alternans in atrial myocytes.

Authors:  Lothar A Blatter; Jens Kockskämper; Katherine A Sheehan; Aleksey V Zima; Jörg Hüser; Stephen L Lipsius
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

2.  Analysis of inositol phosphates in heart tissue using anion-exchange high-performance liquid chromatography.

Authors:  E A Woodcock
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

3.  Activation of Phospholipase C β by Gβγ and Gαq Involves C-Terminal Rearrangement to Release Autoinhibition.

Authors:  Isaac J Fisher; Meredith L Jenkins; Gregory G Tall; John E Burke; Alan V Smrcka
Journal:  Structure       Date:  2020-05-12       Impact factor: 5.006

4.  The role of inositol 1,4,5-trisphosphate receptors in Ca(2+) signalling and the generation of arrhythmias in rat atrial myocytes.

Authors:  Lauren Mackenzie; Martin D Bootman; Mika Laine; Michael J Berridge; Jan Thuring; Andrew Holmes; Wen-Hong Li; Peter Lipp
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

5.  Inositol-1,4,5-trisphosphate mass content in isolated perfused rat heart during alpha-1-adrenoceptor stimulation.

Authors:  S Hanem; M Enger; T Skomedal; J B Osnes
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 6.  Inositol phosphates in the heart: controversy and consensus.

Authors:  E A Woodcock
Journal:  J Mol Med (Berl)       Date:  1995-06       Impact factor: 4.599

7.  Reduction in Gh protein expression is associated with cytodifferentiation of vascular smooth muscle cells.

Authors:  E Vincan; C B Neylon; A N Jacobsen; E A Woodcock
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

Review 8.  Phosphoinositide-generated messengers in cardiac signal transduction.

Authors:  H A van Heugten; Y E Eskildsen-Helmond; H W de Jonge; K Bezstarosti; J M Lamers
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.